Taken together, these data support a paradigm shift in which survival prediction models in advanced PCa may benefit from prioritizing systemic and bone turnover markers, such as Hb and ALP, over the traditional histopathologic or laboratory prognosticators. Here, GSTM1 is linked to posterior cortical atrophy.